Results 191 to 200 of about 18,093 (248)

Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study. [PDF]

open access: yesParasit Vectors
Opoku NO   +14 more
europepmc   +1 more source

Therapeutic and Formulation Advances of Ivermectin in Veterinary and Human Medicine. [PDF]

open access: yesPharmaceutics
Gernandt N   +5 more
europepmc   +1 more source

Onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment on morbidity prevalence: a modelling study

open access: yes
Dixon M   +8 more
europepmc   +1 more source

Strengthening dermatology capacity and competency in resource-limited settings: A viewpoint. [PDF]

open access: yesPLoS Negl Trop Dis
Wilder-Smith AB   +6 more
europepmc   +1 more source

Progress Toward Onchocerciasis Elimination in Brazil

open access: hybrid
João Luiz Pereira de Araujo   +7 more
openalex   +1 more source

Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in Cameroon between 1971 and 2020. [PDF]

open access: yesPLoS Negl Trop Dis
Niamsi-Emalio Y   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy